Home / News / Event #674191 SEC EDGAR published this disclosure on 2026-08-12. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗ accession 0001493152-26-037502
acquired disposed D
code S
direct or indirect D
form 4
is derivative false
issuer name TAKEDA PHARMACEUTICAL CO LTD
label Open market sale
Source record & verification Dates, provenance and technical details
Context links are based on the recorded entity type Recorded payload Structured source data
Recorded payload JSON payload as stored after parsing {
"accession": "0001493152-26-037502",
"acquired_disposed": "D",
"code": "S",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "TAKEDA PHARMACEUTICAL CO LTD",
"label": "Open market sale",
"person_name": "Bitetti Teresa Marie",
"price": 17.1,
"role": "President, OBU",
"security": "American Depositary Shares",
"shares": 50012,
"shares_owned_after": 252010,
"source_path": "edgar/data/1977608/0001493152-26-037502.txt",
"ticker": "TAK",
"transaction_date": "2026-08-10",
"value": 855205.2000000001
}
Evidence-based analysis facts, provenance and explicit model coverage Descriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.